NovoCure Ltd Income Statement
NVCR / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
NovoCure Ltd reported $655M in revenue and $136M in net loss for FY2025. Revenue has grown at a 41.3% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $655.4M | $605.2M | $509.3M | $537.8M | $535.0M | $494.4M | $351.3M | $248.1M | $177.0M | $82.9M | $33.1M | $15.5M | $10.4M |
| Cost of Revenue | $166.9M | $137.2M | $128.3M | $114.9M | $114.9M | $106.5M | $88.6M | $80.0M | $55.6M | $39.9M | $20.6M | $10.0M | $7.0M |
| Gross Profit | $488.5M | $468.0M | $381.1M | $423.0M | $420.2M | $387.9M | $262.7M | $168.0M | $121.4M | $36.6M | $12.5M | $5.5M | $3.3M |
| SG&A Expense | $177.7M | $189.8M | $164.1M | $132.8M | $126.1M | $107.4M | $87.9M | $73.5M | $59.1M | $51.0M | $33.9M | $24.1M | $16.6M |
| R&D Expense | $224.5M | $209.6M | $223.1M | $206.1M | $201.3M | $132.0M | $79.0M | $50.6M | $38.1M | $41.5M | $43.7M | $40.4M | $34.8M |
| Operating Income | -$153.8M | -$170.5M | -$232.9M | -$89.5M | -$44.3M | $30.4M | -$914.0K | -$33.7M | -$39.3M | -$115.3M | -$104.0M | -$80.2M | -$64.5M |
| Interest Expense | $22.2M | $11.7M | $4.9M | $8.1M | $8.8M | $18.1M | $14.6M | $16.9M | $11.7M | $7.3M | $3.2M | $287.0K | $12.8M |
| Income Tax | -$23.0K | $37.5M | $15.3M | $10.7M | $6.3M | -$1.7M | -$1.6M | $17.6M | $13.2M | $10.4M | $4.4M | $382.0K | $353.0K |
| Net Income | -$136.2M | -$168.6M | -$207.0M | -$92.5M | -$58.4M | $19.8M | -$7.2M | -$63.6M | -$61.7M | -$131.8M | -$111.6M | -$80.7M | -$77.4M |
| EPS (Basic) | -$1.95 | -$0.88 | -$0.56 | $0.20 | -$0.07 | -$0.69 | -$0.13 | - | - | - | - | - | - |
| EPS (Diluted) | -$1.95 | -$0.88 | -$0.56 | $0.18 | -$0.07 | -$0.69 | -$0.13 | -$1.54 | -$3.67 | -$6.46 | -$6.73 | - | - |
| Shares Outstanding | 108.5M | 107.1M | 105.0M | 104.0M | 102.3M | 99.5M | 93.3M | 89.5M | 87.1M | 83.8M | 13.4M | 12.5M | 11.5M |
| Gross Margin | 74.5% | 77.3% | 74.8% | 78.6% | 78.5% | 78.5% | 74.8% | 67.7% | 68.6% | 44.2% | 37.7% | 35.2% | 32.3% |
| Operating Margin | -23.5% | -28.2% | -45.7% | -16.6% | -8.3% | 6.2% | -0.3% | -13.6% | -22.2% | -139.1% | -314.3% | - | - |
| Profit Margin | -20.8% | -27.9% | -40.6% | -17.2% | -10.9% | 4.0% | -2.1% | -25.6% | -34.8% | -159.1% | -337.2% | - | - |